BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18936085)

  • 21. Human follicular fluid from superovulated women inhibits progesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat.
    Gordon A; Aguilar R; Garrido-Gracia JC; Bellido C; Millán Y; Guil-Luna S; García-Velasco JA; Bellido-Muñoz E; de las Mulas JM; Sánchez-Criado JE
    J Endocrinol Invest; 2010 Sep; 33(8):564-70. PubMed ID: 20479571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen.
    Gabriel SM; Simpkins JW; Kalra SP
    Endocrinology; 1983 Nov; 113(5):1806-11. PubMed ID: 6313330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of recombinant inhibin on gonadotropin secretion during proestrus and estrus in the rat.
    Rivier C; Schwall R; Mason A; Burton L; Vale W
    Endocrinology; 1991 May; 128(5):2223-8. PubMed ID: 1902163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of estrogen receptor-alpha induces gonadotroph progesterone receptor expression and action differently in young and middle-aged ovariectomized rats.
    Gordon A; Aguilar R; Garrido-Gracia JC; Guil-Luna S; Sánchez-Cespedes R; Millán Y; Martín de las Mulas J; Sánchez-Criado JE
    Hum Reprod; 2009 Oct; 24(10):2618-28. PubMed ID: 19574278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of RU486 injected on proestrous morning on LHRH, LH and 17beta-estradiol secretion during the estrous cycle in rat.
    Tébar M; Ruiz A; González D; Hernández G; Alonso R; Sánchez-Criado JE
    J Physiol Biochem; 1998 Jun; 54(2):91-7. PubMed ID: 9858129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
    Jain MR; Pu S; Kalra PS; Kalra SP
    Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway.
    Turgeon JL; Waring DW
    Mol Endocrinol; 1994 Jul; 8(7):860-9. PubMed ID: 7984148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms.
    Attardi B; Scott R; Pfaff D; Fink G
    J Neuroendocrinol; 2007 Dec; 19(12):988-1000. PubMed ID: 18001329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CI628 inhibits follicle-stimulating hormone (FSH)-induced increases in FSH receptors of the rat ovary: requirement of estradiol for FSH action.
    Tonetta SA; Spicer LJ; Ireland JJ
    Endocrinology; 1985 Feb; 116(2):715-22. PubMed ID: 2981676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiovulatory potential of progesterone antagonists correlates with a down-regulation of progesterone receptors in the hypothalamus, pituitary and ovaries.
    Donath J; Nishino Y; Schulz T; Michna H
    Ann Anat; 2000 Mar; 182(2):143-50. PubMed ID: 10755181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that atrazine and diaminochlorotriazine inhibit the estrogen/progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen receptor action.
    McMullin TS; Andersen ME; Nagahara A; Lund TD; Pak T; Handa RJ; Hanneman WH
    Toxicol Sci; 2004 Jun; 79(2):278-86. PubMed ID: 15056801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible role of luteinizing hormone and follicle-stimulating hormone in modulating inhibin secretion and expression during the estrous cycle of the rat.
    Rivier C; Roberts V; Vale W
    Endocrinology; 1989 Aug; 125(2):876-82. PubMed ID: 2502378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiprogestins suppress basal and activin-stimulated follicle-stimulating hormone secretion in an estrogen-dependent manner.
    Szabo M; Kilen SM; Saberi S; Ringstrom SJ; Schwartz NB
    Endocrinology; 1998 May; 139(5):2223-8. PubMed ID: 9564826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles.
    Natraj U; Richards JS
    Endocrinology; 1993 Aug; 133(2):761-9. PubMed ID: 8344215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of an antiserum to luteinizing hormone-releasing hormone on the progesterone-induced luteinizing hormone surge in ovariectomized, estrogen-primed rats.
    Lu KH; Yen SS
    Endocrinology; 1980 Mar; 106(3):867-70. PubMed ID: 6986264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge.
    Park OK; Mayo KE
    Mol Endocrinol; 1991 Jul; 5(7):967-78. PubMed ID: 1840636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrous cycle stage-dependent effects of neuropeptide-Y on luteinizing hormone (LH)-releasing hormone-stimulated LH and follicle-stimulating hormone secretion from anterior pituitary fragments in vitro.
    Bauer-Dantoin AC; Knox KL; Schwartz NB; Levine JE
    Endocrinology; 1993 Dec; 133(6):2413-7. PubMed ID: 8243258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex steroids influence LH-RH-receptor interaction.
    Spona J
    Endocrinol Exp; 1975 Sep; 9(3):167-76. PubMed ID: 171140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.